この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2004/6/291 分で読めます
Prescription Drug Products; Digoxin Elixir; Extension to Obtain Marketing Approval
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is announcing that it will continue to exercise enforcement discretion to assure the continued availability of digoxin elixirs after June 28, 2004, allowing manufacturers to continue to market these products without approved applications until December 28, 2004. FDA is granting this extension to give manufacturers of digoxin elixir additional time to obtain marketing approval and bring products to market.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →